The analysts all agree that cash flows from the compounding pharmacy will help fund Adamis’ operations until FDA approval of its Epi-pen. Moreover, they note that Adamis' acquisition of the state-of-the-art compounding pharmacy was a brilliant acquisition. They paid less than 5x EBITDA at a time when the stock price for Adamis was about $10 a share.
Thanks startruxx, your paid bashing is a great help to those of us who are averaging down every time the stock drops another dime. We'll be well over $6.00 before the end of the year - probably over $10.00. If you wish to watch out for yourself, you - and your shortie boss who pays you to waste your time on this thread - will need to cover or you will have your proverbial tit caught in the ringer.
Wow! It is hard to believe that the shorts and their paid bashers could take ADMP down to the low 3s. Only $3.25?? Note that Short interest was up to 546,022 shares on 5/31/2016. Back on 5/13/2016 it was 377,295 shares and on 4/29/16, it was only 267,451 shares. Looks illegal - since this short buildup was up before the FDA letter. But you gotta love it. Smart people are loading up each day with each new drop. The company is now selling at about 1/5th of its actual value according to the analysts. Oh, by the way, the company will be reporting actual income and earnings for the first time this quarter. It also bunch of valuable prospects in its arsenal - each of which probably has a current value of $4 per share or more. Buy or die - say I.
Wow - what a weak for analyst positions on RGLS. Cowan & Company on Wednesday 6/8 reiterated a Buy on the stock. On Tuesday 6/07/16 both Chardan Capital and Needham & Co. maintained their Buy calls. On Tuesday 6/07/16 Ewa Dimensions upgraded the stock from Underweight to Hold. And, of course, today the company is presenting at the Jefferies 2016 Healthcare Conference.
Well, thank you all for the ridiculously priced shares of ADMP. I'm now a large shareholder (not quite required to report to the SEC though). The value of US Compounding, Inc. ALONE is worth the current price of $4.10. Their revenues of $20 million or more in each of the last two years are going to grow rapidly. They have a large sales and marketing team and robust manufacturing capabilities - which will be synergistic someday - but right now they are simply accretive to Adamis' overall value. Up til now Adamis had no income - remember? Now they have considerable income obtained with shares valued at 2 -1/2 times their current value. Do you remember that this division alone will generate at least $5 million in operating income over the next 12 months and create product worth $50 million per year within 2 years? At 1x sales - that is $4 a share. Not counting the half dozen drugs that this company (after all these years) finally has in the final stages of approval. Before the split - a current share of stock was 17 shares and they were worth $1000s of dollars. It's taken a long time coming - but everyone seems to have forgotten that there was a reason for it.
Look at the last 6 headlines. They are all about the same thing - over and over. The shorts are desperate. Too bad for them the SEC investigation appears to be over. The shorts keep having their lawyer friends and the stooge, Zacks, release the same news release over and over. Ha, ha. Sooner or later they will die like rats!!
June 01, 2016 9:59 pm ET
IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces an Investigation of Claims against Iconix Brand Group, Inc. and Advises Investors to Contact the Firm BusinessWire
7:58 pm ET
Robbins Arroyo LLP: Iconix Brand Group, Inc. (ICON) Misled Shareholders According to a Recently Filed Class Action BusinessWire
May 27, 2016 9:21 am ET
Iconix Brand (ICON) Faces Investigation by a Law Firm Zacks
May 24, 2016 6:39 pm ET
Federman & Sherwood Investigates Iconix Brand Group, Inc. for Possible Violations of Federal Securities Laws BusinessWire
May 20, 2016 9:15 am ET
Iconix Brand (ICON) Falls on Investigation by a Law Firm Zacks
May 18, 2016 1:19 pm ET
The Shuman Law Firm Investigates Iconix Brand Group, Inc. BusinessWire
From the Nasdaq site: Short interest (in shares)
So short interest is DOWN 4 Million shares in the last 4 months. There is always going to be a baseline short position in any marketable stock. Finally, we are back at that level for ICON.
I wonder what these shorts know (to end that - $28,000,000 investment) - that the bashers on this board are missing?
Kenman, your $300,000 in profits, how does that compare to your losses? Was any of that was made by shorting the stock? Does that include any fees paid to you by shorts for bashing the stock? As you know, I am a firm believer in everything that you say without the slightest reservation. So I'm happy for you that you own 10,000 shares and that the price is going down just as you expected. It obviously was the result that you desired and it is good to see you being so successful.
Kenman - I absolutely without question and with complete certainly believe your defamatory suggestions of fraud by the company (which appear to be coming from someone who is paid by the shorts to bash the stock on this message board - for why else would you still be here every day?). Of course I'm not going to believe the highly respected and successful turnaround expert - Peter Cuneo - who has just been cleaning up after an SEC investigation, because there can be no doubt that he wants to bring on another SEC investigation to keep him warm in his retirement years. Yes - during this low interest quarter, you and your shorty friends are holding this stock underwater - but it has a lot of buoyancy and it will bounce back.
Boy, you would have to be a complete dolt to hold a short position here. It is obvious that there has been market manipulation (down) to get the stock price this low ($7.50). It has been going on for a couple of weeks. They've obviously had the cooperation of a few of the market makers. They've issued law firm press releases to highlight pointless and redundant claims of litigation (as if ICON hasn't had 10 pending lawsuits or more at any given time since it's inception). I thank them for allow me to load up at bargain basement prices (
Here we are again. Price unbelievably low. $7.50 on a stock making $1.25 this year. Shorts caught because they've spent BIG money to get the stock price down here, but still no one is selling. Bashers out in force posting negative comments on this rarely followed message board.(Outdated methodology) They've started the press release mill (like releasing ancient lawsuit press releases over again). They want sales of ICON so they can cover - but time is running out. Last short squeeze took us over $10.00.
Oh, silly me. I thought that management said in the conference call that it will have accumulated over 50% of the cash needed to pay off those converts (which are due in March 2018) by the due date. It sounded like they plan to be in a position to reduce their debt load by $200MM in 2018. If so, that should improve the debt leverage and reduce refinancing costs at the same time.
Hard not to dream of the days when this stock will be somewhat fairly valued again. The current P/E of 6 (on $1.25 - the low end of management's earnings estimate for 2016) is a bit oversold - don't you think? At a mere P/E of 8 (a 12.5% annual rate of return), this stock should sell at $10.00 right now. At a fair P/E of 15 (rate of return 6.7% per annum)- we'd be at $18.75. And that's without any future increases in earnings due to long term growth. We've got excellent management. Witness the last two deals closed - BBC and Bagley. Both netted about $10MM in gains for the company. They've been building up brands and reselling them for years. That's in addition to licensing revenues. With this SEC thing behind them, the company will be increasing deal making - not decreasing it. This will complement the rebound in retail that's coming. People can't not buy clothes for very long...